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How did the study come about?
The Baseline Southall and Brent Studies
(1988–91)
Comparisons of chronic disease in migrant and host
populations have provided valuable aetiological
insights, and furthered the understanding of balance
between genetic and environmental influences on the
disease. The UK is home to several migrant groups, the
largest and longest established being of Indian Asian
and African Caribbean origins. One of the earliest
and largest waves of Indian Asian migration to the UK
followed the 1947 partition of India. As these migrants
reached middle age in the 1970s, it became increasingly
apparent, both in the UK and elsewhere overseas, that
this population was at greatly increased risk of cardio-
vascular disease (CVD), both coronary heart disease
(CHD) and stroke, compared with host populations.1–6
Initial exploration of conventional risk factors, such as
diet, total cholesterol, smoking and blood pressure,
showed that these differed markedly between
ethnic subgroups and were often more favourable
than the host UK population, and therefore these fac-
tors could not account for the excess CVD risk observed
in all Indian Asian subgroups (such as Indians of
Gujarati/Hindu Punjabi/Sikh Punjabi origin, Pakistanis
and Bangladeshis). Notably, a greater prevalence of
diabetes was found in all Indian Asian subgroups,
which linked with the observation of greater fasting
hyperinsulinaemia, led us to hypothesize that insulin
resistance, associated with upper body fat distribu-
tion, could underpin the excess diabetes, hypertriglycer-
idaemia and CHD in Indian Asians.3 This hypothesis
was tested in the Southall study, a large population-
based inter-ethnic cross-sectional study of middle-
aged men and women carried out between 1988 and
1990.7
A large number of migrants of Black African descent
from the Caribbean and West Africa also arrived in
the UK during the post–Second World War period,
encouraged by the UK government in an effort to
fill the many vacancies for key workers.8 As these
African Caribbean migrants were also reaching
middle age in the 1980s, an intriguing paradox was
emerging in the UK, which had been noted previously
in similar populations in the USA and Caribbean.
Despite high rates of diabetes, people of African and
African Caribbean descent had relatively low CHD
risks compared with White European ethnic origin
populations.6,9–11 In stark contrast, stroke-related
mortality was doubled and mortality from hyper-
tensive disease was increased between 4-fold (men)
and 7-fold (women) in Caribbean-born migrants
compared with the general UK population.10 The
latter finding was especially puzzling, as previous
population-based studies did not provide unequivocal
evidence that blood pressure or the prevalence
of hypertension were elevated in people of Black
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African descent.12–14 Exploration of the diabetes/CHD
paradox and definitive exploration of ethnic differ-
ences in resting and ambulatory blood pressure
formed the basis of the Brent population-based
comparison of African Caribbean and European
middle-aged men and women.15
This cross-sectional comparison followed the suc-
cessful completion of the Southall study in 1990.
The Southall and Brent studies were performed ac-
cording to identical protocols by the same team,
using the same equipments and hospital laboratories.
The geographical areas of the baseline studies are con-
tiguous and the two studies were conducted consecu-
tively. In order to improve statistical power, the two
baseline data sets have now been amalgamated.
Together, the Southall and Brent studies form the
basis of the largest UK population-based tri-ethnic
cohort.
Southall And Brent REvisited (2008–13)
Cross-sectional analysis of the Southall and Brent
studies yielded important information on disease
prevalence and associations (see below), but could
only hint at causality. In addition, first-generation mi-
grants as a cohort are now reaching pensionable age,
where disease burden is anticipated to be high, yet
little data exist for this age group. In particular,
heart failure, as a consequence of CHD, diabetes and
hypertension, a rarity in middle-aged individuals, now
becomes especially prevalent, causing more than
one-third of all deaths in older age.16 Finally, interim
mortality follow-up analyses of this cohort showed
striking ethnic differences in the effects of dysglycae-
mia on CVD mortality (see What Has It Found? sec-
tion), adding urgency to the need for follow-up study
of cardiometabolic health and the mechanisms under-
lying ethnic differences.
The Southall And Brent REvisited (SABRE) study
was initiated in 2008 as a 20-year follow-up of the
two baseline studies.
Ethics committee approval was obtained for both
baseline studies as well as for SABRE.
What does the study cover and
how has this changed?
Broadly, the baseline studies were set up to examine,
in cross section, the associations between components
of the insulin resistance or ‘metabolic’ syndrome in
each of the three ethnic groups and to determine
how these associations might underlie the higher
rates of CHD in Indian Asians and the higher rates
of hypertensive target organ damage and stroke in
African Caribbeans.
The SABRE follow-up study (2008–13) continues to
focus on ethnic differences in cardiometabolic risk.
We are quantifying cardiometabolic events during
the follow-up period in both surviving and deceased
participants using questionnaires to participants and
primary-care record review, and in survivors, by mea-
suring subclinical CVD. We will address the following
primary research questions:
 Is the greater risk of CHD in Indian Asians
explained by a hyperglycaemia-associated adverse
lipid and lipoprotein profile compared with
Europeans?
 Is the greater risk of stroke and magnetic reson-
ance imaging (MRI)-detected subclinical cerebral
infarct in African Caribbeans explained by
hyperglycaemia-associated loss of nocturnal blood
pressure dipping compared with Europeans?
 Does subclinical circulatory disease differ by ethni-
city, and if so, is this predicted and explained by
differences in expression of the cardiometabolic
syndrome?
 Do current thresholds for risk-factor interventions
need modifying for UK ethnic minority groups?
Who is in the sample?
The Southall study (1988–90) was the first of the two
baseline studies.7 A target sample of 3000 men aged
40–69 years of Indian Asian and European descent
was chosen to have 90% power to detect at 5% sig-
nificance a relative risk of 1.5 for prevalent CHD in
Indian Asian compared with European men. The
sample was assembled from two sources selected for
the ethnic mix of the potential participants: industrial
workforces and general practitioners’ (GPs’) lists. The
general practice component was supplemented with a
target sample of 600 women and was drawn from 16
general practices in the Southall and Greenford areas
of west London. A small number of African Caribbean
participants (223) who appeared in this sampling
frame were also included. For the industrial sample,
four factories in West London were chosen on the
basis of the ethnic mix of their workforces. The over-
all response rate for the Southall study was 64% for
Indian Asian men (1421 out of 2230) and 67% in
non-Asian men (1772 out of 2660) (Table 1).
In the Brent Study (1990–91),15 the target sample
was based on the lists of six general practices.
A sample of 300 participants in each sex and
ethnic group (European and African Caribbean)
aged 40–69 years was calculated to have 90% power
to detect a difference of 3% in mean systolic and dia-
stolic blood pressures at a 5% level of significance.
With the help of practice staff, potential participants
were assigned to one of the five ethnic groups:
European, South Asian, African Caribbean, other
and unknown. The relative proportions of these
groups varied by general practice, although the pro-
portion of participants of unknown ethnicity was
small. A random sample from the combined African
Caribbean and unknown group, stratified by 5-year
age group and sex, was selected, and an equal
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sample of Europeans was chosen in the same manner.
The response rate was 58% (Table 1). Although it was
not possible to assign ethnicity to all potential partici-
pants invited, the response rates were similar in the
two ethnic groups in those participants in whom
ethnicity could be assigned.
All South Asian and African Caribbean participants
are first-generation migrants to the UK.
How often have they been
followed up?
Since the baseline studies, participants have been
flagged for mortality by the Office for National
Statistics and analyses of death certificate data
have been performed. A pilot postal follow-up in
176 people randomly selected from both baseline
studies was conducted in 2004. This feasibility assess-
ment informed the grant application for follow-up of
the entire study population. The current study
(SABRE) is the first follow-up of survivors.
What has been measured?
At baseline, participants were invited to attend clinics
in local hospitals and health centres for a health
check after an overnight fast. Prior to the examin-
ation, participants were asked to complete a self-
administered questionnaire that included items on
past medical history (including diabetes and the
Rose angina questionnaire,17 medication, smoking,
alcohol intake, physical activity, dietary information
and occupation, together with questions regarding
current and childhood socio-economic circumstances.
Ethnicity was described by the interviewer based on
appearance and parental origin. Clinical measure-
ments were performed to a standard protocol and
are listed in Table 2. Baseline characteristics are
detailed in Table 3.
In addition to the above, Brent study participants
were invited to take part in substudies including
echocardiography, retinal photography and 24-h
ambulatory blood pressure monitoring (Table 2).
In the SABRE follow-up, all participants currently
living in England or Wales are invited by letter to
attend the study clinic at St Mary’s Hospital London
following an overnight fast. Taxi transport is provided
for local participants and travel costs are reimbursed
for those who live outside the London area.
Participants are asked to complete a detailed ques-
tionnaire regarding medical history, lifestyle and
socio-economic circumstances. They then undergo a
series of comprehensive clinical measurements as
detailed in Table 2.
We offer home visits by a trained nurse for
those who live locally but who are unable or unwill-
ing to attend the clinic. These home visits include
anthropometric and blood pressure measurements,
plus urine and fasting blood samples. As part of the
informed consent procedure, participants can also
choose to limit their participation to completion of
the questionnaire and/or consent for medical record
review.
Cardiovascular and diabetes-related events that
have occurred since the baseline studies are identified
from primary-care medical record review and from
Table 1 Summary of Southall and Brent study recruitment (1988–91) and response rates and survival to
SABRE follow-up (commencing 2008)
Delivered
invitations Agreed, n (%) Ethnicity
Survivors
(as on 1 July 2008)
Southall M F
Workplace 1141 808 (71%) E: 1516 246 E: 1430 (81%)
IA: 1420 291 SA: 1466 (86%)
General practice 4713 2946 (63%) AC 209 14 AC: 193 (87%)
Other: 59
Brent
General practice 2088 1218 (58%) E: 272 313 E: 513 (88%)
AC: 244 334 AC: 525 (91%)
Other: 55
Southall and Brent
Combined studies 7942 4972 (63%) E: 1787 559 E: 1943 (83%)
IA: 1420 291 SA: 1466 (86%)
AC: 453 348 AC: 718 (90%)
Other: 114
E: European; IA: Indian Asian; AC: African Caribbean.
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Table 2 Southall and Brent baseline studies and SABRE
follow-up measurements
Investigations/measurements
Baseline
studies
(1988–91)
SABRE
study
follow-up
(2008–12)
Age of participants, years 40–69 57–90
Anthropometrics
Circumferences: waist, hip, thigh 3 3
Sagittal diameter 3 –
Truncal and peripheral skinfold
thicknesses
3 –
Height 3 3
Leg length – 3
Weight 3 3
Body fat
Bioimpedance
Percent body fat – 3
Fat mass – 3
CT (for fat distribution)
Thigh (single slice, mid-thigh) – 3
Abdomen (single slice L4) – 3
Bloods
Fasting
Glucose, insulin 3 3
HbA1c – 3
Total cholesterol, triglycerides,
HDL cholesterol
3 3
Serum creatinine – 3
Liver function tests – 3
Lipoprotein subfractions
(NMR spectroscopy)
– 3
Apolipoprotein a/b 3 (subset) 3
APOE genotype 3 (subset) 3
Inflammatory markers (TNFa,
CRP, IL-6, NT ProBNP, PAI 1)
3 3
Stored blood for future analyses 3 3
Two-hour post-glucose challenge
(if not known to have diabetes)
Glucose, insulin 3 3
Total cholesterol, triglycerides,
HDL cholesterol
3 –
Urine
Timed overnight urine collection
for albumin excretion rate
3 (subset) –
Albumin creatinine ratio 3 3
Blood pressure
Resting
Brachial sitting 3 3
Brachial lying – 3
Ankle lying – 3
24-hour ambulatory blood pressure 3 (subset in
Brent only)
3
ECG (resting, 12 lead) 3 3
(continued)
Table 2 Continued
Investigations/measurements
Baseline
studies
(1988–91)
SABRE
study
follow-up
(2008–12)
Echocardiography and vascular measurements
2D echocardiography 3 (subset in
Brent only)
3
Left ventricular function,
wall thickness, cavity
dimensions, Speckle tracking
(ventricular dyssynchrony
tissue velocity, strain and
rotation)
– 3
Tissue Doppler imaging
Tissue velocities – 3
3Dk echocardiography
Left ventricular volumes,
wall masses, cavity dimensions,
ventricular function and
ventricular dyssynchrony
– 3
Left ventricular remodelling index – 3
Vascular
Carotid intima media thickness – 3
Pulse wave velocity
(carotid-femoral)
– 3
Wave intensity analysis – 3
Coronary artery calcification (CT) – 3
Cerebral MRI
White matter lesions, sulcal and
ventricular grades
– 3
Non-haemorrhagic infarcts and
haemorrhagic lesions
– 3
Hippocampal volumes – 3
Cognitive function testing
Participant tests, plus key
informant perspective
– 3
Eye photography
Retinal photography (four-field,
both eyes)(analysis for retinal
vascular architecture,
age-related
macular degeneration and
diabetic retinopathy)
3 (subset in
Brent)
3
Lens photography (opacities and
cataracts)
– 3
Visual acuity – 3
Medical history
Participant recall 3 3
Primary-care medical record review – 3
Lifestyle/behaviours 3 3
Smoking, alcohol consumption,
physical activity
3 3
Diet 3 –
Socio-economic circumstances
Childhood 3 –
Current 3
Quality of life (EQ5D) – 3
Activities of daily living – 3
Family history of diabetes/ heart
disease
– 3
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participant questionnaire responses. Medical record
review is undertaken by trained members of the re-
search team in local general practices and at primary
care trusts where the records of deceased participants
are stored. In the cases where participants have
moved outside the local area, their GP is asked to
complete the same case report form.
Reminder letters are sent to non-responders after
2 weeks. If there is no response after a reminder,
then trained interviewers from the National Centre
for Social Research (NatCen) carry out home visits
in the north-west London area, with the aim of
recruiting participants for full clinical follow-up
and/or completion of the questionnaire and/or consent
for medical record review.
What is attrition like?
As SABRE represents the first individual follow-up of
surviving participants and is in the mid-recruitment
phase, data on attrition are limited. We used the NHS
tracing system to trace the cohort in 2008. Currently,
we are nearly 2 years into the follow-up study and
have approached 2925 of 4127 surviving participants.
We have identified 431 people who either do not have
a valid contact address or who were away when we
attempted to contact them. This represents 8% of
Europeans, 11% of Indian Asians and 19% of
African Caribbeans. Although 22% of survivors (38%
of Europeans, 7% of Indian Asians and 8% of African
Caribbeans) have moved to areas outside north-west
London, the majority of dispersion is to other areas of
greater London or the surrounding counties within a
80 km radius.
In the feasibility study of 176 people, non-responders
(n¼ 60) tended to have worse baseline risk factor
profiles than responders, although the differences
were seldom significant and not consistently in one
direction. Based on the feasibility study, we expect over-
all response rates to be 70, 65 and 60% among European,
Indian Asians and African Caribbeans, respectively.
After nearly 2 years into the follow-up study, among
2925 approached, 61% of Europeans, 56% of Indian
Asians and 52% of African Caribbeans have agreed to
participate. We expect these rates to be substantially
boosted following a further attempt to revisit or trace
those who were initially away or whose addresses
were unknown, and most importantly, following
home visits by NatCen interviewers in the north-west
London area.
At the expected response rates (70, 65, 60%), SABRE
will have 580% power at 5% significance to examine
the effects of major risk factors for CHD and stroke
separately and to examine the different magnitudes
of effect of diabetes [detectable hazard ratios in whole
study population: new CHD events (fatal and
non-fatal): Indian Asians vs Europeans: 1.4, African
Caribbeans vs Europeans: 0.6, and for new stroke
events (fatal and non-fatal): Indian Asians vs
Europeans: 1.7, African Caribbeans vs Europeans: 2.0].
What has it found?
The baseline Southall study was the first to report the
high prevalence of the insulin resistance or cardiome-
tabolic syndrome in association with a striking ten-
dency to central obesity in British Indian Asian
migrants—these findings were common to diverse
South Asian subgroups such as Hindus, Sikhs and
Muslims. These findings led us to suggest that insulin
resistance might be the underlying cause of the
increased susceptibility to CHD and stroke among
Indian Asians.7,18 The Brent study, on the other
hand, reported that while African Caribbeans were
as dysglycaemic, they were less hyperinsulinaemic
than Indian Asians. They were not centrally obese
and had favourable blood lipid profiles, suggesting
that the causes of diabetes in African Caribbeans
may be different from those in Indian Asians and
this might also explain why CHD mortality in
African Caribbeans is low, despite the high prevalence
of diabetes and hypertension.19 In addition, resting
and ambulatory blood pressure recordings in a sub-
group of Europeans and African Caribbeans (n¼ 319)
demonstrated that the higher resting blood pressures
in African Caribbean women may be enough to ex-
plain their excess stroke mortality, but that blood
pressure did not explain the excess stroke rates in
African Caribbean men. Smaller declines in nocturnal
blood pressure may further contribute to the excess of
hypertensive target organ damage in African
Caribbeans.15 Echocardiographic study demonstrated
that African Caribbeans had greater left ventricular
structural impairment than Europeans, and that
remodelling patterns of the left ventricle in response
to hypertension differed, with greater wall thickening
and cavity narrowing compared with Europeans.20
This pattern of remodelling in other studies is found
to have more adverse implications for downstream
mortality than patterns more commonly observed in
people of European origin.
Analyses of cardiovascular mortality during the first
16 years of follow-up suggested that diabetes [defined
retrospectively by World Health Organisation
(WHO) 1999 criteria21] exerts a remarkably ‘toxic’
effect with regard to both CHD and stroke mortality
in people of Indian Asian origin.22 In people of
African Caribbean origin, diabetes ‘toxicity’ was par-
ticularly striking in association with stroke mortality.
At 16 years of follow-up, African Caribbeans with dia-
betes were six times more likely to die from stroke
compared with Europeans [incidence rate ratio
adjusted for age, systolic blood pressure and smoking
status: 6.7 (95% confidence interval 1.4–32.5,
P¼ 0.018)].23 Further unpublished analyses demon-
strated similar effects on mortality in both Indian
Asians and African Caribbeans in association with
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Table 3 Baseline characteristics (1988–91) in the combined Southall and Brent study population
MeansSD, medians
(25th, 75th percentiles)
European
men
Indian
Asian men
P-value
(IA vs E)
African
Caribbean men
P-value
(AC vs E)
Men
Number 1787 1420 453
Age 52.7 7.1 50.7 7.0 <0.001 53.5 5.8 0.035
Height, cm 174.2 6.9 169.8 6.5 <0.001 171.9 6.7 <0.001
Weight, kg 79.6 12.9 74.5 11.0 <0.001 74.5 10.3 0.010
Waist circumference, cm 91.9 11.0 92.9 9.6 0.013 89.4 9.8 <0.001
Hip circumference, cm 97.3 6.7 94.6 6.2 <0.001 94.9 6.4 <0.001
Waist-to-hip ratio 0.94 0.07 0.98 0.06 <0.001 0.94 0.06 0.66
Body mass index, kg/m2 26.2 3.9 25.8 3.3 0.052 26.3 3.3 0.24
Systolic blood pressure, mmHg 121 (112, 133) 123 (113, 136) <0.001 126 (116, 137) <0.001
Diastolic blood pressure, mmHg 77 (70, 84) 80 (74, 87) <0.001 80 (73, 89) <0.001
Treated hypertension 150 (8%) 190 (13%) <0.001 85 (19%) <0.001
Prior CHD 169 (9%) 130 (9%) 0.79 23 (5%) 0.003
Prior stroke 19 (1%) 25 (2%) 0.088 12 (3%) 0.009
Known diabetes 55 (3%) 185 (13%) <0.001 46 (10%) <0.001
Diabetes by WHO 1999 criteria, n (%)b 127 (7%) 311 (22%) <0.001 83 (18%) <0.001
Impaired fasting glucose (IFG) (isolated)b 171 (10%) 121 (9%) 0.31 52 (12%) 0.21
Impaired glucose tolerance (IGT)
(isolated or both IFG and IGT)b
50 (3%) 70 (5%) 0.002 44 (10%) <0.001
Fasting glucose, mmol/l 5.4 (5.1, 5.8) 5.5 (5.1, 6.0) <0.001 5.6 (5.2, 6.1) <0.001
Fasting insulin, pmol/l 51.4 (34.0, 75.0) 75.0 (50.7, 110.4) <0.001 59.0 (39.5, 86.3) <0.001
Two-hour post-glucose load glucose, mmol/l 5.0 (4.2, 5.9) 5.5 (4.6, 6.6) <0.001 5.8 (5.0, 7.1) <0.001
Two-hour post-glucose load insulin, pmol/l 136.8
(80.6, 238.9)
283.4
(163.9, 517.4)
<0.001 155.6
(104.2, 250.0)
0.02
HOMA insulin resistance 1.8 (1.1, 2.7) 2.6 (1.7, 3.9) <0.001 2.1 (1.3, 3.1) 0.003
Total cholesterol 5.8 (5.1, 6.6) 5.7 (5.0, 6.4) <0.001 5.4 (4.7, 6.2) <0.001
Fasting triglycerides, mmol/l 1.4 (1.0, 2.0) 1.6 (1.1, 2.3) <0.001 1.0 (0.8, 1.5) <0.001
HDL cholesterol, mmol/l 1.3 (1.0, 1.5) 1.2 (1.0, 1.4) <0.001 1.4 (1.2, 1.7) <0.001
Microalbuminuria, n/total number
with overnight urine collectiona (%)
64/1055 (6%) 44/763 (6%) 0.79 20/288 (7%) 0.59
Urine AER 4.0 (2.9, 6.1) 3.5 (2.5, 6.2) <0.001 5.4 (3.6, 8.9) <0.001
Smoking status, % never/ex/current 29/40/32 74/11/15 <0.001 54/19/26 <0.001
Physical activity score MJ/week 3.9 (1.2, 5.1) 3.5 (1, 4) <0.001 3.7 (1.2, 5.8) 0.010
Women
Number 559 291 348
Age 52.9 6.7 50.7 6.8 <0.001 52.9 6.0 0.94
Height, cm 161.1 6.4 154.7 6.4 <0.001 160.9 5.5 0.77
Weight, kg 67.6 13.2 65.2 10.7 0.005 76.1 13.4 <0.001
Waist circumference, cm 80.0 12.2 85.8 11.0 <0.001 88.7 11.4 <0.001
Hip circumference, cm 99.0 8.7 98.3 8.1 0.26 102.8 9.1 <0.001
Waist-to-hip ratio 0.81 0.08 0.87 0.09 <0.001 0.86 0.08 <0.001
Body mass index, kg/m2 26.1 4.8 27.3 4.6 <0.001 29.4 4.8 <0.001
Systolic blood pressure, mmHg 118 (108, 128) 123 (109, 136) <0.001 130 (119, 142) <0.001
Diastolic blood pressure, mmHg 75 (68, 81) 76 (70, 83) <0.001 81 (73, 89) <0.001
Treated hypertension 59 (11%) 38 (13%) 0.28 102 (29%) <0.001
(continued)
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fasting and post-challenge glucose in both univariate
and multivariate analyses (unpublished data, Figure
1). These interactions between ethnicity and dysgly-
caemia could not be explained by conventional risk
factors (refs22,23 and unpublished data) and were evi-
dent even in those whose diabetes had not been diag-
nosed before the first baseline study visit (Figure 1).
However, numbers of deaths at this stage of follow-up
were small, and it is apparent that there is an urgent
need to assess non-fatal events and subclinical CVD
in association with dysglycaemia in our surviving
cohort.
What are the main strengths and
weaknesses?
This is the largest tri-ethnic UK cohort and now has
a 20-year follow-up. The South Asian and African
Caribbean participants form a unique group of British
first-generation migrants—a precious resource. The
baseline studies were performed to a strict protocol
and have resulted in detailed phenotyping of
the group in middle age. The participants are now
of an age to be at maximal risk of cardiovascular
events, and current follow-up involves extensive
cardiovascular assessment using state-of-the-art
techniques. Particular strengths lie in the range
and detail of the follow-up measurements of subclinical
disease. These include indicators of suboptimal heart
function and structure. Added value will be gained
from validation of 2D echocardiographic measure-
ments against gold standard 3D techniques for assess-
ment of cardiac volumes. Cognitive function and MRI
assessment of subclinical cerebral changes will provide
unique data in this older population. Quantification
of body-fat distribution using computed tomography
(CT) together with glucose tolerance testing and
measurements of lipoprotein subfractions will inform
understanding of the mechanisms underlying the
marked ethnic differences in the manifestations of
insulin resistance. Studies involving ethnic group
comparisons not only increase understanding
of genetic and lifestyle effects on disease risk but
also form important natural experiments where
the marked ethnic differentials in clustering of risk
factors enable elucidation of the relative roles of
each in disease causation. Finally, using baseline
Table 3 Continued
MeansSD, medians
(25th, 75th percentiles)
European
women
Indian
Asian
women
P-value
(IA vs E)
African
Caribbean
women
P-value
(AC vs E)
Prior CHD 32 (6%) 4 (1%) 0.003 17 (5%) 0.59
Prior stroke 7 (1%) 3 (1%) 0.78 6 (2%) 0.56
Known diabetes 13 (2%) 27 (9%) <0.001 39 (11%) <0.001
Diabetes by WHO 1999 criteriab 24 (4%) 44 (15%) <0.001 68 (20%) <0.001
IFG (isolated)b 36 (6%) 3 (1%) <0.001 18 (5%) 0.44
IGT (isolated or both IFG and IGT)b 34 (6%) 20 (7%) 0.64 47 (14%) <0.001
Fasting glucose, mmol/l 5.3 (4.9, 5.7) 5.1 (4.8, 5.6) 0.005 5.6 (5.1, 6.2) <0.001
Fasting insulin, pmol/l 36.8 (25.6, 56.0) 53.1 (37.5, 80.6) <0.001 64.4 (41.6, 90.3) <0.001
Two-hour post-glucose load glucose, mmol/l 5.7 (5.0, 6.6) 5.7 (94.9) 0.52 6.6 (5.7, 7.8) <0.001
Two-hour post-glucose load insulin, pmol/l 148.3
(97.2, 226.8)
309.7
(185.4, 526.4)
<0.001 255.2
(175.4, 388.2)
0.002
HOMA insulin resistance 1.3 (0.8, 2.0) 1.7 (1.2, 2.9) <0.001 2.4 (1.5, 3.4) <0.001
Total cholesterol, mmol/l 6.0 (5.2, 6.9) 5.7 (5.0, 6.4) <0.001 5.6 (4.8, 6.5) <0.001
Fasting triglycerides, mmol/l 1.2 (0.9, 1.7) 1.4 (1.1, 1.9) <0.001 1.1 (0.8, 1.4) <0.001
HDL cholesterol, mmol/l 1.6 (1.3, 1.9) 1.4 (1.2, 1.6) <0.001 1.6 (1.4, 1.9) 0.20
Microalbuminuria, n/total number
with overnight urine collectiona (%)
12/433 (3%) 6/200 (3%) 0.88 22/254 (8%) 0.001
Urine AER 3.1 (2.2, 4.4) 3.1 (2.0, 5.0) 0.96 4.7 (3.2, 8.0) <0.001
Smoking status, % never, ex, current
Physical activity score MJ/week 3.8 (1.2, 5.1) 1.5 (1.0, 3.5) <0.001 3.7 (1.2, 5.8) 0.52
AER: albumin excretion rate; HOMA: homeostasis model assessment.
aOvernight urine collection not complete for whole study population.
bWHO 1999 criteria applied retrospectively.
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risk factor associations with fatal and non-fatal events,
SABRE will uniquely be able to inform ethnicity-specific
thresholds for CVD risk factor intervention in the UK.
The weaknesses of the study lie mainly in the single
follow-up at 20 years and in loss to follow-up.
However, we are conducting review of medical records
together with participant recall of major cardiovascu-
lar events since the baseline studies. This complemen-
tary approach has been shown to provide a valid
method of identifying morbid events during lengthy
follow-up periods.24 In addition, we have full mortal-
ity follow-up since the baseline follow-up, and review
of medical records will complement death certificate
information for deceased participants. Loss to clinical
follow-up is likely to be substantial, particularly in
older migrant populations, as retirement often in-
volves a return to the home country for protracted
periods. However, our pilot study data and initial re-
sponses indicate that most European and Indian
Asian participants are traceable to a UK address and
are willing to take part in the follow-up study. It is
our experience that African Caribbeans tend to favour
face-to-face contact over a postal approach for recruit-
ment; hence intensive efforts will be made to trace
and visit African Caribbean non-responders.
Can I get hold of the data? Where
can I find out more?
Data will be stored by the UK Data Archive from 2014.
We welcome proposals from 2014 onwards for collab-
orative study of baseline and follow-up data. Please
contact Professor Nish Chaturvedi (n.chaturvedi@
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Figure 1 Southall and Brent studies mortality follow-up to 2007. (a) Age-adjusted univariate and multivariate Cox
regression analysis of associations of measured risk factors with CHD mortality in Europeans and Indian Asians.
(b) Age-adjusted univariate and multivariate Cox regression analysis of associations of measured risk factors with
stroke mortality in Europeans, Indian Asians and African Caribbeans. Multivariate models adjusted for triglyceride,
waist circumference, insulin, cholesterol, blood pressure and smoking. Py¼ interaction P-value: Indian Asians vs Europeans.
Pz¼ interaction P-value: African Caribbeans vs Europeans. Diabetes defined according to WHO criteria, 199921
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imperial.ac.uk) for further information. Please also
visit the SABRE study website http://www.sabrestudy
.org.uk.
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